And when muscle drops, metabolism slows, fatigue increases, and long-term weight regain becomes more likely
It is a specialist drug for a rare condition, prescribed by gastroenterologists, and it has nothing to do with weight loss
[1] Close monitoring and multidisciplinary support involving bariatric surgeons, endocrinologists, dietitians, and specialist nurses optimise treatment outcomes and ensure patient safety throughout the intervention
77 (suppl 9)
Human evidence - Phase 3 TRIUMPH-1 (Eli Lilly, May 21, 2026) 2,339 adults with obesity or overweight without diabetes
Ensuring safety, maintaining strict laboratory practices, and recognising its research-only status are equally important